195 related articles for article (PubMed ID: 15307862)
1. Surveillance for hepatocellular carcinoma in elderly Italian patients with cirrhosis: effects on cancer staging and patient survival.
Trevisani F; Cantarini MC; Labate AM; De Notariis S; Rapaccini G; Farinati F; Del Poggio P; Di Nolfo MA; Benvegnù L; Zoli M; Borzio F; Bernardi M;
Am J Gastroenterol; 2004 Aug; 99(8):1470-6. PubMed ID: 15307862
[TBL] [Abstract][Full Text] [Related]
2. Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience).
Trevisani F; De Notariis S; Rapaccini G; Farinati F; Benvegnù L; Zoli M; Grazi GL; Del PP; Di N; Bernardi M;
Am J Gastroenterol; 2002 Mar; 97(3):734-44. PubMed ID: 11922571
[TBL] [Abstract][Full Text] [Related]
3. Surveillance for early diagnosis of hepatocellular carcinoma: is it effective in intermediate/advanced cirrhosis?
Trevisani F; Santi V; Gramenzi A; Di Nolfo MA; Del Poggio P; Benvegnù L; Rapaccini G; Farinati F; Zoli M; Borzio F; Giannini EG; Caturelli E; Bernardi M;
Am J Gastroenterol; 2007 Nov; 102(11):2448-57; quiz 2458. PubMed ID: 17617210
[TBL] [Abstract][Full Text] [Related]
4. Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival.
Santi V; Trevisani F; Gramenzi A; Grignaschi A; Mirici-Cappa F; Del Poggio P; Di Nolfo MA; Benvegnù L; Farinati F; Zoli M; Giannini EG; Borzio F; Caturelli E; Chiaramonte M; Bernardi M;
J Hepatol; 2010 Aug; 53(2):291-7. PubMed ID: 20483497
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and cost of a hepatocellular carcinoma screening program at an Australian teaching hospital.
Qian MY; Yuwei J R; Angus P; Schelleman T; Johnson L; Gow P
J Gastroenterol Hepatol; 2010 May; 25(5):951-6. PubMed ID: 20546449
[TBL] [Abstract][Full Text] [Related]
6. Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease.
Ando E; Kuromatsu R; Tanaka M; Takada A; Fukushima N; Sumie S; Nagaoka S; Akiyoshi J; Inoue K; Torimura T; Kumashiro R; Ueno T; Sata M
J Clin Gastroenterol; 2006; 40(10):942-8. PubMed ID: 17063116
[TBL] [Abstract][Full Text] [Related]
7. Screening for hepatocellular carcinoma in patients with advanced cirrhosis.
Chalasani N; Horlander JC; Said A; Hoen H; Kopecky KK; Stockberger SM; Manam R; Kwo PY; Lumeng L
Am J Gastroenterol; 1999 Oct; 94(10):2988-93. PubMed ID: 10520857
[TBL] [Abstract][Full Text] [Related]
8. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.
Bolondi L; Sofia S; Siringo S; Gaiani S; Casali A; Zironi G; Piscaglia F; Gramantieri L; Zanetti M; Sherman M
Gut; 2001 Feb; 48(2):251-9. PubMed ID: 11156649
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation.
Gambarin-Gelwan M; Wolf DC; Shapiro R; Schwartz ME; Min AD
Am J Gastroenterol; 2000 Jun; 95(6):1535-8. PubMed ID: 10894592
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of AFP and ultrasound tests on hepatocellular carcinoma mortality in HCV-infected patients in the USA.
El-Serag HB; Kramer JR; Chen GJ; Duan Z; Richardson PA; Davila JA
Gut; 2011 Jul; 60(7):992-7. PubMed ID: 21257990
[TBL] [Abstract][Full Text] [Related]
11. Continued value of the serum alpha-fetoprotein test in surveilling at-risk populations for hepatocellular carcinoma.
An J; Kim HI; Chang S; Shim JH
PLoS One; 2020; 15(8):e0238078. PubMed ID: 32845895
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of alpha-fetoprotein staging system for hepatocellular carcinoma in noncirrhotic patients.
Burnett NP; Dunki-Jacobs EM; Callender GG; Anderson RJ; Scoggins CR; McMasters KM; Martin RC
Am Surg; 2013 Jul; 79(7):716-22. PubMed ID: 23816006
[TBL] [Abstract][Full Text] [Related]
13. Management of the single liver nodule in a cirrhotic patient: a decision analysis model.
El-Serag HB; Mallat DB; Rabeneck L
J Clin Gastroenterol; 2005 Feb; 39(2):152-9. PubMed ID: 15681913
[TBL] [Abstract][Full Text] [Related]
14. Early detection of hepatocellular carcinoma in patients with cirrhosis by alphafetoprotein, ultrasound and fine-needle biopsy.
Tremolda F; Benevegnù L; Drago C; Casarin C; Cechetto A; Realdi G; Ruol A
Hepatogastroenterology; 1989 Dec; 36(6):519-21. PubMed ID: 2482242
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
[TBL] [Abstract][Full Text] [Related]
16. A training program for primary care physicians improves the effectiveness of ultrasound surveillance of hepatocellular carcinoma.
Del Poggio P; Olmi S; Ciccarese F; Mazzoleni M; Jazzetti M; Jamoletti C; Mattiello M; Del Poggio A; Portugali V; Stroffolini T
Eur J Gastroenterol Hepatol; 2015 Sep; 27(9):1103-8. PubMed ID: 26049705
[TBL] [Abstract][Full Text] [Related]
17. The Effect of Hepatocellular Carcinoma Surveillance in an Urban Population With Liver Cirrhosis.
Nusbaum JD; Smirniotopoulos J; Wright HC; Dash C; Parpia T; Shechtel J; Chang Y; Loffredo C; Shetty K
J Clin Gastroenterol; 2015; 49(10):e91-5. PubMed ID: 25751372
[TBL] [Abstract][Full Text] [Related]
18. Factors that affect efficacy of ultrasound surveillance for early stage hepatocellular carcinoma in patients with cirrhosis.
Del Poggio P; Olmi S; Ciccarese F; Di Marco M; Rapaccini GL; Benvegnù L; Borzio F; Farinati F; Zoli M; Giannini EG; Caturelli E; Chiaramonte M; Trevisani F;
Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1927-33.e2. PubMed ID: 24582947
[TBL] [Abstract][Full Text] [Related]
19. Natural history of hepatocellular carcinoma.
Colombo M
Ann Ital Chir; 2008; 79(2):91-7. PubMed ID: 18727270
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of early response to hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma using the combination of response evaluation criteria in solid tumors and tumor markers.
Miyaki D; Kawaoka T; Aikata H; Kan H; Fujino H; Fukuhara T; Kobayashi T; Naeshiro N; Honda Y; Tsuge M; Hiramatsu A; Imamura M; Hyogo H; Kawakami Y; Yoshimatsu R; Yamagami T; Awai K; Chayama K
J Gastroenterol Hepatol; 2015 Apr; 30(4):726-32. PubMed ID: 25311578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
